Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2206 to 2220 of 9008 results

  1. Doravirine–islatravir for treating HIV-1 in people with virological suppression on bictegravir, emtricitabine and tenofovir alafenamide combination treatment [TSID12171]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  2. Dabigatran etexilate for the secondary prevention of stroke after an embolic stroke of undetermined source [ID1417]

    Awaiting development Reference number: GID-TA10426 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  3. Secondary care management of malignant hypertension

    Awaiting development Reference number: GID-QS10107 Expected publication date: TBC

    Quality standard
    Awaiting development

  4. Oesophageal String Test

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  5. Lumella Pre-Eclampsia point-of-care test for assessing pre-eclampsia risk (MT687)

    Topic prioritisation

    Diagnostics guidance
    Topic prioritisation

  6. Efgartigimod for treating chronic inflammatory demyelinating polyneuropathy [ID6409]: draft guidance

    We are listening to your views on this Technology appraisal guidance. Comments close 18 May 2026.

    Technology appraisal guidance
    In consultation

  7. Acalabrutinib with venetoclax for untreated chronic lymphocytic leukaemia [ID6232]

    In development Reference number: GID-TA11230 Expected publication date:  18 June 2026

    Technology appraisal guidance
    In development

  8. Ex-situ machine perfusion devices for deceased donor liver transplants

    In development Reference number: GID-HTE10066 Expected publication date:  20 August 2026

    Health technology evaluations
    In development

  9. Pegcetacoplan for treating complement 3 glomerulopathy or primary immune-complex membranoproliferative glomerulonephritis in people 12 years and over [ID6489]

    In development Reference number: GID-TA11633 Expected publication date:  18 June 2026

    Technology appraisal guidance
    In development

  10. Oveporexton for treating type 1 narcolepsy [ID6622]: consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

    We are listening to your views on this Technology appraisal guidance. Comments close 21 May 2026.

    Technology appraisal guidance
    In consultation

  11. Botulinum toxin injection to cricopharyngeal muscle for retrograde cricopharyngeal dysfunction (RCPD)

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  12. Thermocoagulation for the treatment of piles and anal fistula

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  13. Parathyroid autofluorescence and parathyroid angiography

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  14. Vedolizumab for treating moderately to severely active ulcerative colitis in people 2 to 17 years [TSID12134]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  15. Ustekinumab for treating moderately to severely active ulcerative colitis in children aged 2 to 17 years [TSID 12128]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation